PPARGC1A and Parkinson disease: Furthermore, FGF21 treatment not only enhanced mitochondrial functions through PGC-1α activation in human dopamine neurons [209], but also showed neuroprotective effects by stimulating the AMPK/PGC-1α axis to promote mitochondrial functions in MPTP-treated PD models [211].